These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18581589)
1. Frequency of Pro475Ser polymorphism of ADAMTS13 gene and its association with ADAMTS-13 activity in the Korean population. Jang MJ; Kim NK; Chong SY; Kim HJ; Lee SJ; Kang MS; Oh D Yonsei Med J; 2008 Jun; 49(3):405-8. PubMed ID: 18581589 [TBL] [Abstract][Full Text] [Related]
2. Absence of Pro475Ser polymorphism in ADAMTS-13 in Caucasians. Bongers TN; De Maat MP; Dippel DW; Uitterlinden AG; Leebeek FW J Thromb Haemost; 2005 Apr; 3(4):805. PubMed ID: 15842379 [No Abstract] [Full Text] [Related]
3. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Martin K; Borgel D; Lerolle N; Feys HB; Trinquart L; Vanhoorelbeke K; Deckmyn H; Legendre P; Diehl JL; Baruch D Crit Care Med; 2007 Oct; 35(10):2375-82. PubMed ID: 17944029 [TBL] [Abstract][Full Text] [Related]
4. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Hyun J; Kim HK; Kim JE; Lim MG; Jung JS; Park S; Cho HI Thromb Res; 2009 May; 124(1):75-9. PubMed ID: 19162307 [TBL] [Abstract][Full Text] [Related]
5. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study. Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487 [TBL] [Abstract][Full Text] [Related]
6. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Nguyen TC; Han YY; Kiss JE; Hall MW; Hassett AC; Jaffe R; Orr RA; Janosky J; Carcillo JA Crit Care Med; 2008 Oct; 36(10):2878-87. PubMed ID: 18828196 [TBL] [Abstract][Full Text] [Related]
8. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods. Kremer Hovinga JA; Mottini M; Lämmle B J Thromb Haemost; 2006 May; 4(5):1146-8. PubMed ID: 16689773 [No Abstract] [Full Text] [Related]
9. ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin) and endothelial dysfunction in sepsis: marker or culprit? Levy B; Lacolley P; Regnault V Crit Care Med; 2007 Oct; 35(10):2453-4. PubMed ID: 17885389 [No Abstract] [Full Text] [Related]
10. Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura. Kobayashi T; Wada H; Kamikura Y; Matsumoto T; Mori Y; Kaneko T; Nobori T; Matsumoto M; Fujimura Y; Shiku H Thromb Res; 2007; 119(4):447-52. PubMed ID: 16797677 [TBL] [Abstract][Full Text] [Related]
11. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays. Shelat SG; Ai J; Zheng XL Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417 [TBL] [Abstract][Full Text] [Related]
13. Methodologies and clinical utility of ADAMTS-13 activity testing. Just S Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299 [TBL] [Abstract][Full Text] [Related]
14. Essential role of the disintegrin-like domain in ADAMTS13 function. de Groot R; Bardhan A; Ramroop N; Lane DA; Crawley JT Blood; 2009 May; 113(22):5609-16. PubMed ID: 19234142 [TBL] [Abstract][Full Text] [Related]
15. ADAMTS-13 in Critically Ill Patients With Septic Syndromes and Noninfectious Systemic Inflammatory Response Syndrome. Aibar J; Castro P; Espinosa G; Fernández S; Hernández C; Rinaudo M; Butjosa M; Tàssies D; Reverter JC; Nicolás JM Shock; 2015 Jun; 43(6):556-62. PubMed ID: 25643015 [TBL] [Abstract][Full Text] [Related]